Supply of experimental medicines to support clinical trials - ACTA and NMS
5 May 2020
As part of the Commonwealth Government’s response to COVID-19, the National Medical Stockpile (NMS) will secure supply of a number of experimental medicines for use in clinical trials, when those medicines cannot be obtained through usual supply chains.
Currently, the NMS has a supply of hydroxychloroquine and invites investigators who may be interested in securing supply from the NMS to contact the NMS through email@example.com
Following this initial contact, the Department of Health will provide advice on further information that is required.
There is no closing date for applications as such, but for this initial round, investigators are asked to contact the Department by COB Friday 14 May.
The Tasmanian Department of Health supports and promotes research in our hospitals and clinical services.
The Research Governance Unit provides advice in respect to research in Tasmanian public health services, and liaises with other jurisdictions on research initiatives.
The Department funds the ethical review of research projects, that involve patients, clients and staff members of public health services, by the University of Tasmania HREC.
The Department also works with local hospitals and federal government agencies to help attract research programs and funding to the state so that research can positively impact on the health of all Tasmanians.
Note: These pages are being updated and revamped in preparation for the release and implementation of the Research Governance Policy Framework - please be aware that information may be incomplete or be a placeholder for a future/final version. If you need any assistance please contact firstname.lastname@example.org.